(S)-3-Chloro-1,2-propanediol (CAS 60827-45-4) Market (2026): Market Leaders Powering Global Pharmaceutical Synthesis

MARKET INSIGHTS

Global (S)-3-Chloro-1,2-propanediol (CAS 60827-45-4) market size was valued at USD 28.4 million in 2025. The market is projected to grow from USD 30.1 million in 2026 to USD 52.7 million by 2034, exhibiting a CAGR of 6.4% during the forecast period.

(S)-3-Chloro-1,2-propanediol, also known as (S)-3-MCPD, is a chiral organochlorine compound with the molecular formula C₃H₇ClO₂. It is a colorless to pale yellow viscous liquid primarily recognized as a chiral building block in asymmetric synthesis and pharmaceutical intermediate manufacturing. The compound plays a significant role in the production of active pharmaceutical ingredients (APIs), agrochemicals, and specialty chemicals, where its specific enantiomeric configuration is essential to achieving desired biological activity and product efficacy.

The market is driven by rising demand for enantiopure intermediates in pharmaceutical synthesis, particularly in the development of cardiovascular and central nervous system drugs. Furthermore, growing investments in asymmetric synthesis technologies and expanding fine chemical manufacturing capacities across Asia‑Pacific are contributing to steady market expansion. Key producers and specialty chemical suppliers operating in this space include TCI Chemicals, Sigma‑Aldrich (Merck KGaA), and Alfa Aesar, among others, offering high‑purity grades to serve research and industrial‑scale applications.

(S)-3-Chloro-1,2-propanediol (CAS 60827-45-4) Market – View in Detailed Research Report

Top 10 Companies in the (S)-3‑Chloro‑1,2‑propanediol Market (2026)

1. MilliporeSigma (Merck KGaA)

Headquarters: Rahway, New Jersey, USA
Key Offering: Pharmaceutical‑grade (S)-3‑Chloro‑1,2‑propanediol for API development and fine chemical synthesis

MilliporeSigma leverages its extensive R&D portfolio to deliver enantiomerically pure intermediates that meet the stringent purity thresholds required by global regulatory bodies. The company’s integrated manufacturing network ensures consistent supply and rapid response to demand shifts in the pharmaceutical sector.

Sustainability Initiatives: Implementation of closed‑loop solvent recovery systems and adoption of renewable energy sources across production sites.

• Advanced chiral resolution technologies
• Global distribution network spanning 50+ countries
• Dedicated quality assurance teams for each product batch
• Continuous improvement programs focused on yield optimization

2. Alfa Aesar (Thermo Fisher Scientific)

Headquarters: Houston, Texas, USA
Key Offering: High‑purity research‑grade (S)-3‑Chloro‑1,2‑propanediol for academic and industrial laboratories

Alfa Aesar provides a broad catalogue of chiral intermediates, emphasizing rapid turnaround for small‑batch orders. Its flexible manufacturing approach supports both pilot‑scale experiments and commercial production needs.

Sustainability Initiatives: Adoption of green chemistry principles in synthesis routes, reducing hazardous waste generation.

• Rapid sample delivery through automated logistics
• Comprehensive certificates of analysis for each shipment
• Partnerships with academic institutions for method development
• Focus on reducing process energy consumption

3. TCI Chemicals

Headquarters: Tokyo, Japan
Key Offering: Pharmaceutical‑grade (S)-3‑Chloro‑1,2‑propanediol with >99% optical purity

TCI’s expertise in asymmetric catalysis allows it to produce high‑quality chiral intermediates efficiently. The company serves a global customer base across pharmaceuticals, agrochemicals, and specialty chemicals.

Sustainability Initiatives: Investment in catalytic processes that lower carbon footprint and solvent usage.

• Advanced chiral catalyst library
• Robust supply chain management with real‑time inventory tracking
• Compliance with REACH and other international safety regulations
• Continuous process optimization for cost efficiency

4. Acros Organics (Thermo Fisher Scientific)

Headquarters: Deerfield, Illinois, USA
Key Offering: Research‑grade (S)-3‑Chloro‑1,2‑propanediol for early‑stage synthesis projects

Acros Organics focuses on delivering high‑performance chiral reagents to the research community, ensuring rapid availability for exploratory chemistry.

Sustainability Initiatives: Implementation of waste‑minimization protocols in laboratory‑scale production.

• Extensive product catalogue for chiral synthesis
• Rapid shipping options for time‑critical projects
• Dedicated technical support for formulation development
• Continuous monitoring of purity and enantiomeric excess

5. Jiangsu Aikon Biopharmaceutical R&D Co., Ltd.

Headquarters: Nanjing, China
Key Offering: GMP‑grade (S)-3‑Chloro‑1,2‑propanediol for large‑scale API manufacturing

Jiangsu Aikon has built a reputation for scalable production of chiral intermediates, serving both domestic and international pharmaceutical clients.

Sustainability Initiatives: Adoption of biocatalytic processes to reduce hazardous waste.

• High‑throughput production lines for enantiopure intermediates
• Strong quality management systems aligned with GMP
• Strategic partnerships with generic drug manufacturers
• Focus on energy efficiency in manufacturing facilities

6. Hairui Chemical Co., Ltd.

Headquarters: Shanghai, China
Key Offering: Technical‑grade (S)-3‑Chloro‑1,2‑propanediol for specialty chemical synthesis

Hairui Chemical specializes in cost‑effective production of fine chemicals, delivering consistent quality for a range of applications.

Sustainability Initiatives: Implementation of closed‑loop water recycling systems.

• Cost‑competitive pricing for technical‑grade products
• Robust quality control protocols for optical purity
• Flexible production scheduling to meet client demands
• Commitment to environmental stewardship in operations

7. Fluorochem Ltd.

Headquarters: London, United Kingdom
Key Offering: High‑purity (S)-3‑Chloro‑1,2‑propanediol for advanced research and industrial applications

Fluorochem’s niche focus on specialty fluorinated intermediates extends to chiral organochlorines, providing tailored solutions for complex synthesis routes.

Sustainability Initiatives: Use of low‑toxicity solvents and energy‑efficient reactors.

• Specialized expertise in chlorinated intermediates
• Global distribution network with dedicated logistics teams
• Compliance with ISO 9001 and ISO 14001 standards
• Continuous improvement of reaction efficiencies

8. Synchem UG & Co. KG

Headquarters: Bremen, Germany
Key Offering: Custom synthesis of (S)-3‑Chloro‑1,2‑propanediol for API and fine chemical projects

Synchem offers bespoke manufacturing services, allowing clients to specify purity levels and production volumes tailored to their needs.

Sustainability Initiatives: Adoption of green chemistry guidelines in process design.

• Custom synthesis capabilities for niche applications
• Strong focus on process scalability and reproducibility
• Dedicated project management teams for client collaboration
• Robust safety protocols for handling chlorinated intermediates

9. Merck KGaA (MilliporeSigma)

Headquarters: Darmstadt, Germany (global headquarters) and Rahway, New Jersey, USA (MilliporeSigma division)
Key Offering: Pharmaceutical‑grade (S)-3‑Chloro‑1,2‑propanediol with comprehensive analytical support

Merck KGaA’s integrated research and manufacturing infrastructure ensures consistent supply of high‑quality chiral intermediates across the pharmaceutical value chain.

Sustainability Initiatives: Implementation of renewable energy sources and waste‑reduction programs across global sites.

• Integrated R&D and production pipelines for rapid innovation
• Extensive global distribution and logistics network
• Strong regulatory compliance framework for all products
• Commitment to reducing environmental impact through process optimization

10. Kureha Corporation

Headquarters: Tokyo, Japan
Key Offering: High‑purity (S)-3‑Chloro‑1,2‑propanediol for pharmaceutical intermediates and specialty chemicals

Kureha’s expertise in chiral synthesis and fine chemical manufacturing positions it as a reliable supplier for advanced pharmaceutical projects.

Sustainability Initiatives: Adoption of low‑energy catalytic processes and solvent‑free reaction routes.

• Advanced chiral catalyst development
• Strong focus on energy efficiency in production
• Comprehensive analytical services for product verification
• Global supply chain resilience through diversified manufacturing sites

(S)-3-Chloro-1,2-propanediol (CAS 60827-45-4) Market – View in Detailed Research Report

(S)-3-Chloro-1,2-propanediol (CAS 60827-45-4) Market – View in Detailed Research Report

Market Outlook

The forecast period will witness a steady rise in demand for enantiopure intermediates as pharmaceutical companies intensify development of chiral drugs. The shift toward outsourcing early‑stage synthesis to CDMOs will further broaden the client base for high‑purity (S)-3‑Chloro‑1,2‑propanediol, reinforcing its position as a core building block in API manufacturing.

Future Trends

• Expansion of biocatalytic production platforms to lower costs and improve sustainability.
• Integration of continuous flow reactors for higher throughput and consistent stereoselectivity.
• Growing emphasis on single‑enantiomer crop protection agents, creating new demand in agrochemicals.
• Increased regulatory scrutiny on chiral purity, driving higher quality standards across the supply chain.